These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 17170079

  • 21. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N, Takahashi-Yanaga F, Fukada K, Shiraishi F, Taba Y, Miwa Y, Morimoto S, Iida M, Sasaguri T.
    Biochem Pharmacol; 2007 May 01; 73(9):1318-29. PubMed ID: 17270149
    [Abstract] [Full Text] [Related]

  • 22. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP, Moraes MS, Rocha KM, Eichler CB, Hajj GN, Schwindt TT, Armelin HA.
    J Mol Endocrinol; 2004 Dec 01; 33(3):623-38. PubMed ID: 15591023
    [Abstract] [Full Text] [Related]

  • 23. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
    Zhang Y, Sif S, DeWille J.
    J Cell Biochem; 2007 Dec 01; 102(5):1256-70. PubMed ID: 17471507
    [Abstract] [Full Text] [Related]

  • 24. Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element.
    Flick MB, Sapi E, Kacinski BM.
    J Cell Biochem; 2002 Dec 01; 85(1):10-23. PubMed ID: 11891846
    [Abstract] [Full Text] [Related]

  • 25. Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells.
    Jiang H, Yu J, Guo H, Song H, Chen S.
    Biochem Biophys Res Commun; 2008 Mar 28; 368(1):1-5. PubMed ID: 18242580
    [Abstract] [Full Text] [Related]

  • 26. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 28; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 27. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
    Zhu CY, Li CY, Li Y, Zhan YQ, Li YH, Xu CW, Xu WX, Sun HB, Yang XM.
    Cell Death Differ; 2009 Mar 28; 16(3):395-405. PubMed ID: 19008924
    [Abstract] [Full Text] [Related]

  • 28. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin.
    Pizzoferrato E, Liu Y, Gambotto A, Armstrong MJ, Stang MT, Gooding WE, Alber SM, Shand SH, Watkins SC, Storkus WJ, Yim JH.
    Cancer Res; 2004 Nov 15; 64(22):8381-8. PubMed ID: 15548708
    [Abstract] [Full Text] [Related]

  • 29. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
    Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB, Liu S.
    Oncogene; 2002 Apr 18; 21(17):2613-22. PubMed ID: 11965534
    [Abstract] [Full Text] [Related]

  • 30. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L, Chiang KY, Zhu N, Findley HW, Zhou M.
    Exp Hematol; 2007 Jun 18; 35(6):957-66. PubMed ID: 17533050
    [Abstract] [Full Text] [Related]

  • 31. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY, Christopeit M, Chen Y, Geletu M, Behre G.
    Exp Hematol; 2008 Nov 18; 36(11):1449-60. PubMed ID: 18687517
    [Abstract] [Full Text] [Related]

  • 32. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.
    Mol Cell Biol; 2007 Nov 18; 27(21):7703-17. PubMed ID: 17785436
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R, Tsuji N, Moriai M, Kobayashi D, Watanabe N.
    Breast Cancer Res Treat; 2009 Sep 18; 117(2):261-71. PubMed ID: 18815881
    [Abstract] [Full Text] [Related]

  • 35. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG.
    Cancer Res; 2008 May 01; 68(9):3152-60. PubMed ID: 18451140
    [Abstract] [Full Text] [Related]

  • 36. The protective effect of phorbol esters on Fas-mediated apoptosis in T cells. Transcriptional and postranscriptional regulation.
    Herrant M, Luciano F, Loubat A, Auberger P.
    Oncogene; 2002 Jul 25; 21(32):4957-68. PubMed ID: 12118374
    [Abstract] [Full Text] [Related]

  • 37. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S.
    Int J Oncol; 2005 Oct 25; 27(4):1151-7. PubMed ID: 16142334
    [Abstract] [Full Text] [Related]

  • 38. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Yoo J, Lee YJ.
    Mol Pharmacol; 2007 Dec 25; 72(6):1586-92. PubMed ID: 17848598
    [Abstract] [Full Text] [Related]

  • 39. Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.
    Zhang L, Wali A, Ramana CV, Rishi AK.
    Cancer Res; 2007 Nov 01; 67(21):10198-206. PubMed ID: 17974960
    [Abstract] [Full Text] [Related]

  • 40. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.